CoChat

Metabolic Syndrome, Mild Cognitive Impairment and Dementia

Panza, F., Frisardi, V., Seripa, D., P. Imbimbo, B., Sancarlo, D., D'Onofrio, G., Addante, F., Paris, F., Pilotto, A., Solfrizzi, V. · 2011 · Current Alzheimer Research
Cited by 79

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

At present, the search for preventive strategies for cognitive decline and dementia appears to be of crucial importance, given that the therapeutic options currently available have demonstrated limited efficacy. Cumulative epidemiological evidence suggested that vascular and vascular-related factors may be important for the development of age-related cognitive decline (ARCD), mild cognitive impairment (MCI), and cognitive decline of degenerative (Alzheimer's disease, AD) or vascular origin (vascular dementia, VaD). Among vascular-related factors, metabolic syndrome (MetS) has been associated with the reduced risk of predementia syndromes (ARCD and MCI), overall dementia, and VaD, but contrasting findings also exist on the possible role of MetS in AD. In the next future, trials could then be undertaken to determine if modifications of these risks including inflammation, another factor probably related to MetS, could lower risk of developing cognitive decline. If MetS is associated with increased risk of developing cognitive impairment, then early identification and treatment of these individuals at risk might offer new avenues for disease course modification. Future research aimed at identifying mechanisms that underlie comorbid associations will not only provide important insights into the causes and interdependencies of predementia and dementia syndromes, but will also inspire novel strategies for treating and preventing these disorders. At present, vascular risk factor management could be decisive in delaying the onset of dementia syndromes or in preventing the progression of predementia syndromes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/156720511796391818

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 79

Metadata

Authors
Panza, F., Frisardi, V., Seripa, D., P. Imbimbo, B., Sancarlo, D., D'Onofrio, G., Addante, F., Paris, F., Pilotto, A., & Solfrizzi, V.
Venue
Current Alzheimer Research
Published
2011-08-01
Volume
8
Issue
5
Pages
492-509
ISSN
1567-2050 (ISSN-L)
OpenAlex
W1976203166
Cited by
79
References
52
FWCI
3.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Syndrome, Mild Cognitive Impairment and Dementia. https://app.cochat.ai/papers/10.2174/156720511796391818
The paper
Panza, F., Frisardi, V., Seripa, D., P. Imbimbo, B., Sancarlo, D., D'Onofrio, G., Addante, F., Paris, F., Pilotto, A., & Solfrizzi, V. (2011). Metabolic Syndrome, Mild Cognitive Impairment and Dementia. Current Alzheimer Research. https://doi.org/10.2174/156720511796391818

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.